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Background: Amyotrophic lateral sclerosis (ALS) leads to chronic respiratory failure. Diaphragmatic dysfunction, a
major driver of dyspnea and mortality, is associated with a shift of the burden of ventilation to extradiaphragmatic
inspiratory muscles, including neck muscles. Besides, energy expenditure is often abnormally high in ALS, and this is
associated with a negative prognostic value. We hypothesized that noninvasive ventilation (NIV) would relieve
inspiratory neck muscles and reduce resting energy expenditure (REE).
Methods: Using indirect calorimetry, we measured REE during spontaneous breathing (REESB) and NIV (REENIV) in 16
ALS patients with diaphragmatic dysfunction, during the first 3 months of NIV. Measured values were compared
with predicted REE (REEpred)(Harris-Benedict equation).
Results: NIV abolished inspiratory neck muscle activity. Even though our patients were not hypermetabolic, on the
contrary, with a REESB that was lower than REEpred (average 11%), NIV did reduce energy expenditure. Indeed,
median REENIV, in this population with a mean body mass index of 21.4 kg.m
-2, was 1149 kcal/24 h [interquartile
970-1309], lower than REESB (1197 kcal/24 h, 1054-1402; mean difference 7%; p = 0.03, Wilcoxon). REESB and REENIV
were correlated with forced vital capacity and maximal inspiratory pressure.
Conclusions: NIV can reduce energy expenditure in ALS patients probably by alleviating the ventilatory burden
imposed on inspiratory neck muscles to compensate diaphragm weakness. It remains to be elucidated whether or
not, in which population, and to what extent, NIV can be beneficial in ALS through the corresponding reduction in
energy expenditure.
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Inspiratory neck musclesBackground
Amyotrophic lateral sclerosis (ALS) is a degenerative
disease that affects motor neurones in the cerebral
cortex, brainstem and spinal cord, with ensuing atrophy
of skeletal muscles. Respiratory failure develops when
respiratory motor neurones are involved. ALS-related
respiratory failure causes major suffering and is a leading
cause of death [1]. Mechanical ventilation, most often
administered non-invasively (NIV), is currently the only
treatment for ALS-related respiratory failure. It prolongs* Correspondence: jesus.gonzalez@psl.aphp.fr
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unless otherwise stated.survival and improves quality of life [2]. Diaphragm
weakness is a major determinant of ALS-related respira-
tory failure [3,4].
A large proportion of ALS patients exhibit hyperme-
tabolism [5-7], defined as an increase in resting energy
expenditure (REE). Yet REE is a determinant of body
weight and weight loss, that both have a documented
negative prognostic impact in ALS [8-10].
Patients with ALS-related diaphragm weakness often ex-
hibit strong phasic activity of inspiratory neck muscles —
the so-called "respiratory pulse"— [3]. These muscles can
be abnormally powerful at producing negative intratho-
racic pressures for inspiration [11]. This can be interpreted
as a compensatory mechanism to maintain ventilation: in
ALS patients with diaphragm paralysis, vital capacity (VC)
is directly correlated with the inspiratory pressurel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of ALS patients at initiation of





Age (years) 68 [56.5-73]
Gender (male/female) 12/4
BMI (kg/m2) 21.4 [19.1-26.6]
Smoking (yes/no) 10/6
Neurological assessment
ALS-FRS-R score 31 [26.5-35]
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some cases, the phasic inspiratory activity of neck muscles
extends during rapid-eye-movement (REM) sleep [4].
There therefore appears to be a shift of the inspiratory
burden from the diaphragm to inspiratory neck muscles
when the ALS degenerative process involves the phrenic
motoneurones.
We hypothesized that extradiaphragmatic inspiratory
muscles including inspiratory neck muscles contribute
to "resting" energy expenditure in ALS patients with dia-
phragm weakness. To test this hypothesis we compared
resting energy expenditure (REE) in ALS patients during
spontaneous breathing and under NIV.Norris bulbar score 35 [26.2-38]
Respiratory assessment
Dyspnea score on MMRC scale 3 [1-3.5]
Inspiratory contraction of inspiratory neck
muscles during quiet breathing in supine
position (yes/no)
16/0
Inspiratory contraction of inspiratory neck
muscles during indirect calorimetry in sitting
position (yes/no)
11/5
PaCO2 (mmHg) 45 [42.5-48]
PaO2 (mmHg) 73 [66.5-77.5]
Bicarbonate (mmol/l) 28 [27-29.5]
Time spent with SpO2 < 90%
(% of recording time)
30 [6.2-72]
FVC sitting (ml) 1990 [1140-2045]Methods
Patients
This was an exploratory "proof of concept" study conducted
in a convenience sample of 16 patients with probable or
certain ALS according to the revised El Escorial criteria [12]
(Table 1). The study was conducted in the Paris (France)
ALS reference center, in a 1600-bed tertiary university
hospital. This study was conducted in accordance with the
amended Declaration of Helsinki. The appropriate French
regulatory and ethical authority (Comité de Protection
des Personnes Ile-de-France 6, La Pitié-Salpêtrière, Paris,
decision #102-12) approved the protocol, and written
informed consent was obtained from all patients.FVC sitting (% predicted) 47 [35-54]
FVC supine (ml) 1650 [847-2182]
FVC supine (% predicted) 38.5 [30-58]
PiMAX (cmH2O) 31 [19.7-58.2]
PiMAX (% predicted) 37 [19.5-55.2]
SNIP (cmH2O) 32 [16.5-40.2]
SNIP (% predicted) 39 [23.2-42.7]
Abbreviations: ALS-FRS-R revised Amyotrophic Lateral Sclerosis - Functional
Rating Scale, BMI Body Mass Index, FVC Forced Vital Capacity, PaO2 arterialInclusion criteria
To be eligible for inclusion in this study, patients had to
have been placed on NIV indication defined according to
current criteria, [13] for at least 24 hours and up to 3 months
(± 1 week). NIV had to be considered to be adequate, either
immediately or after the first NIV adjustments [14]. Patients
had to present signs of diaphragmatic dysfunction including
respiratory pulse in the supine position.oxygen tension, PaCO2 arterial carbon dioxide tension, PiMAX maximal
inspiratory mouth pressure (measured from functional residual capacity; best
of three maneuvers; data missing in 5 patients), SNIP Sniff Nasal Inspiratory
Pressure (measured from functional residual capacity; best of ten maneuvers;
data missing in 1 patients —in whom MIP was available—),
SpO2 transcutaneous pulsed oxygen saturation.
Dyspnea was evaluated using the Modified Medical Research Council
(MMRC) scale.
Grade 0: I only get breathless with strenuous exercise.
Grade 1: I get short of breath when hurrying on the level or walking up a slight hill.
Grade 2: I walk slower than people of the same age on the level because of
breathlessness or have to stop for breath when walking at my own pace on
the level.
Grade 3: I stop for breath after walking about 100 yards or after a few minutes
on the level.
Grade 4: I am too breathless to leave the house or I am breathless when dressing.Non-inclusion criteria
Patients with ALS in whom NIV had been started in an
emergency context were not eligible. Patients with a dis-
ease other than ALS likely to alter nutritional status and
metabolic status (renal failure, diabetes or thyroid disease,
recent episode of acute respiratory failure, active infection,
chronic pancreatitis, chronic alcoholism, corticosteroid
therapy, known malignancy) could not be included in the
study.
All in all, over the study period, 24 patients were
eligible among 106 ALS patients seen at the center. Two
of those refused to participate in the study, technical
problems occurred in one case, and recordings were
missed in 5 cases.Assessments
Neurological, respiratory and metabolic assessments
were all performed on the same day.
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The severity of the neurological deficit was evaluated by
the revised ALS Functional Rating Scale (ALS-FRS-R),
which rates the ability to perform activities of daily living
from 0 (total inability) to 48 points (no limitation) and
incorporates respiratory items (dyspnea, orthopnea, re-
spiratory insufficiency). The bulbar section of the Norris
scale was used to quantify bulbar impairment from 0 (no
bulbar function) to 39 points (normal bulbar function).
The date of onset of the symptoms and their initial level
(bulbar or spinal), the date of confirmation of the diag-
nosis, and ongoing treatments (all patients received
treatment with riluzole 50 mg, twice daily) were also
recorded.
Respiratory assessment
Respiratory function was evaluated by arterial blood
gases with spontaneous breathing in room air and by
overnight pulse oximetry (SpO2) recording. Forced Vital
Capacity (FVC) was measured in the supine and sitting
positions with the EasyOne® ultrasound spirometer
(NDD Medical Technologies, Andover, MA, USA). In-
spiratory muscle strength was evaluated by measuring
the maximal inspiratory pressure at the mouth (PiMAX)
and at the nostril ("sniff nasal inspiratory pressure",
SNIP) using a Micro-RPM® digital manometer (Micro
Medical, Chatham, Kent, UK).
Optimization of nocturnal NIV was verified by arterial
blood gases performed in the morning, one hour after
disconnecting the ventilator, nocturnal SpO2 recording
on NIV and detection of leakages by the software inte-
grated into the ventilator [14,15]. Of note, all the
patients were equipped with home ventilators of the
same make and model (Stellar®, Resmed, Bella Vista,
Australia), with the spontaneous-timed pressure support
mode (inspiratory and expiratory trigger).
Nutritional assessment
Nutritional assessment comprised measurement of
height and weight for calculation of body mass index
(BMI), by adopting a cut-off of 20 kg/m2 for malnutri-
tion. Resting energy expenditure (REE) was measured by
indirect calorimetry using a Quark RMR™ apparatus
(Cosmed, Rome, Italy). Measurements were performed
before 10 o’clock in the morning after fasting overnight
and after resting for 20 minutes in a semi-sitting pos-
ition in a quiet room heated to between 20°C and 24°C.
Only values obtained at metabolic steady-state (less
than 5% changes in V'O2, V'CO2 and RQ for at least
15 minutes) were taken into account.
During spontaneous breathing on room air (REESB),
oxygen consumption (V'O2) and CO2 production
(V'CO2) were measured by a sensor fitted to the tip of a
close-fitting oronasal mask. During NIV (REENIV),inspired air is carried from the respirator to the mask
via a single tube. Expired air is delivered into the cham-
ber via a calibrated leak distal to the sensor measuring
V’O2 and V’CO2 (Figure 1). This methodology was
developed in several healthy subjects prior to the study
to ensure that measurement of REE on spontaneous
breathing by the canopy method was equivalent to the
that obtained by the cycle-to-cycle gas analyzer and that
the calibrated leak in the NIV circuit did not induce any
reduction of REE.
Predicted REE (REEpred) was also calculated by the
equation of Harris and Benedict [16]:
for males, REE = 66 + 1.38*weight(kg) + 5*height(cm)-
6.8*age(years)
for females, REE = 655 + 9.7*weight(kg) + 1.8*height
(cm)-4.7*age(years).Statistical analysis
Results were expressed as the median [1st quartile; 3rd
quartile], and nonparametric tests were used for statis-
tical analysis. REE measured on spontaneous breathing
was compared to the predicted value by a Wilcoxon's
test, which was also used to compare REENIV and REESB.
Correlations between metabolic status (REESB, REENIV,
REEpred-REESB, REESB-REENIV) and the various parame-
ters likely to influence metabolic status were analyzed by
Spearman’s rank correlation. The limit of significance
was 5% (P < 0.05).Results
Measurements were performed after the first night on
NIV in 10 cases, and at later time-points in 6 cases (after
32 to 96 nights). The anthropometric characteristics of
the patients included in the study and the results of their
respiratory and neurological assessments are summa-
rized in Table 1. Thirty-one per cent (5/16) of patients
presented an initially bulbar form of ALS. No patient
has a gastrostomy. The first neurological symptoms had
been present for an average of 26.5 [14; 39.2] months.
All patients had received treatment with riluzole for an
average of 13.2 [6.7; 19.5] months. At the time of the as-
sessment, 37% (6/16) of patients had a BMI < 20 kg/m2
and 50% (8/16) of patients reported weight loss greater
than 10% since onset of the disease. None of the patients
had had a percutaneous endoscopic gastrostomy at the
time of the procedure, but 6 of them (all among those
who had lost weight) underwent this procedure in the
following weeks.
REESB was significantly lower than REEpred (1197.3
[1054.7; 1402.6] kcal/24 h vs 1389.5 [1193.9; 1622.6]
kcal/24 h, p = 0.004). The mean REESB / REEpred ratio
was 90 [83; 97]%, with only one patient presenting a
REESB / REEpred ratio greater than 110% (111%).
Figure 1 Schematic representation of measurement of energy expenditure during spontaneous breathing (A) and noninvasive
ventilation (B).
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diurnal and nocturnal alveolar hypoventilation (Table 2).
All patients reported complete or almost complete relief of
dyspnea. Physical examination demonstrated that inspira-
tory neck muscle activity was abolished in every case.
REE was significantly decreased on NIV (REENIV: 1149.2
[970.8; 1309.5] kcal/24 h, p = 0.03 compared to REESB;









VT (ml) 406.8 [289.5-486.8] 535.7 [450.8-578.4] 0.003
RF (/min) 17.6 [14.7-23.9] 15.4 [14.5-18.4] 0.02
Ventilation (l/min) 7.1 [6.5-7.9] 8.3 [7.5-9.9] <0.001
PaCO2 (mmHg) (n=12)* 47 [43-48] 41.5 [38-44] 0.002
PaO2 (mmHg) (n = 12)* 69 [65.7-75.2] 88.5 [70-97.5] 0.005
A-a gradient (mmHg)
(n = 12)*
23.1 [16.6-27.6] 9.2 [3.9-29.3] 0.03
VD (ml) (n = 12)* 117.7 [78.2-141.6] 178.9 [152.6-211.8] 0.01
Time spent with
SpO2 < 90%
(% of recording time)
30 [6.2-72] 1 [1-3] <0.001
Abbreviations: A-a gradient for Alveolar-arterial gradient, PaO2 arterial oxygen
tension, PaCO2 arterial carbon dioxide tension, RF Respiratory Frequency, SpO2
transcutaneous pulsed oxygen saturation, VT for tidal volume, VD dead space
volume (calculated using Bohr formula, note that non invasive ventilation
efficiently corrects PaCO2 in spite of an increased VD -expected-).[-14; -2]% (Figure 2). There was no difference in the
magnitude of this result between the 10 patients studied
immediately after NIV initiation and the 6 patients studied
later.
REESB and REENIV were significantly correlated with
gender, the Norris bulbar score, sitting FVC and PiMAX
(Table 3). There was no other correlation with any of the
anthropometric (BMI, age), respiratory or neurological
(severity, history of disease) variables. The REESB - REENIV
difference did not correlate with any of the collected
variables.
Discussion
This study shows that NIV can acutely decrease resting
energy expenditure in ALS patients with ALS-related
chronic respiratory insufficiency exhibiting signs of
severe diaphragmatic dysfunction.
Study limitations
For the purposes of this proof-of-concept study, we
deliberately selected a small number of patients who were
as homogeneous as possible in terms of the respiratory im-
pact of ALS. Apart from NIV criteria, all patients exhibited
obvious signs of diaphragmatic dysfunction including
increased activity of inspiratory neck muscles, which may
limit extrapolation of our results. Of note, the diagnosis of
diaphragmatic dysfunction was based on physical examin-
ation and phrenic nerve stimulation was not performed to
measure diaphragm strength and to distinguish lower from
Figure 2 Resting energy expenditure (REE) in the study population (box-and-whiskers) with indication of individual data (solid lines)
during spontaneous breathing (REESB) and noninvasive ventilation (REENIV). The limits of the boxes correspond to the 25th and 75th percentiles
of the distribution, with indication of the median as the black solid lines within the boxes. The whiskers represent the 10th and the 90th percentiles,
respectively, and the black dots indicate the extreme values. The gray area corresponds to the interquartile space of REE predicted according to the
equation of Harris and Benedict.
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inspiratory neck muscles by NIV was also not confirmed by
electromyography (but only clinically). If anything, residual
inspiratory neck muscle activity would have underestimated
the effect of NIV on energy expenditure. Similarly, the
patients were studied under a triggered NIV modality:
controlled mechanical ventilation could have resulted in
a larger reduction of REE. Measurement errors with
indirect calorimetry are a major concern, particularly when
comparing two conditions involving different setups. We
took extensive precautions to control for technical issuesTable 3 Significant correlations between resting energy expen
and maximal inspiratory mouth pressure
REESB REEN
Gender 0.523* 0.037-0.809 0.038 0.71
Norris bulbar score 0.582* 0.099-0.843 0.023 0.67
FVC sitting (ml) 0.577* 0.038-0.856 0.039 0.63
PiMAX (cmH2O) 0.826* 0.359-0.962 0.006 0.70
REE, resting energy expenditure; "sb", during spontaneous breathing; "niv", during n
FVC, Forced Vital Capacity; PiMAX, maximal inspiratory mouth pressure.that could have interfered with the measurements, and
extensive preliminary measurements were performed in
normal subjects to check that REE was not affected by
the different setups. The difference between REESB and
REENIV in our patients (median 7%) exceeded the coeffi-
cient of variation of the measurement reported by other
authors under similar conditions 3.5% ± 2.7% -standard
error- in stable mechanically ventilated patients, see
[17] and was also greater than the variability observed
in normal subjects during our in-house preliminary
experiments.diture and gender, Norris bulbar score, forced vital capacity
IV REESB-REENIV
4* 0.337-0.893 0.001 0.282 -0.248;0.683 0.289
7* 0.253-0.883 0.005 0.157-0.386;0.620 0.575
5* -0.022-0.821 0.019 0.079-0.494;0.604 0.798
7* 0.080-0.933 0.033 -0.044 -0.688;0.639 0.910
on invasive ventilation.
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REE and mechanical ventilation: the energy cost of breathing
The contribution of respiratory muscles to REE or oxygen
consumption at rest has been estimated in the literature to
be between 1% [18,19] and 5-7% in normal individuals
[20-23] and in quadriplegics [24]. These estimates were
mostly based on back-extrapolations of the relationship
between V'O2 and load-induced increases in the work of
breathing [25]. This relationship is not linear and can
underestimate the oxygen cost of unloaded breathing. To
avoid this bias, the energy cost of breathing can be derived
from comparisons between energy expenditure measured
during spontaneous breathing and during mechanical
ventilation in the same individuals [26,27]. This approach
implies that respiratory muscles are actually passive during
the measurements performed under mechanical ventilation,
which is not always easy to ascertain. In patients with
chronic obstructive pulmonary disease receiving NIV, Hugli
et al. [28] estimated that respiratory V'O2 was an average of
1.6% of V'O2. This figure was underestimated because NIV
mostly failed to abolish respiratory muscle electromyo-
graphic activity. In addition, the ventilation-induced
reduction in V'O2 was not normally distributed (1.6 ± 6%)
and some patients had respiratory V'O2 values of about
10% of V'O2 [28]. In quadriplegic patients treated with
phrenic stimulation, switching ventilatory assistance from
controlled mechanical ventilation to diaphragm pacing
increased REE by an average of 21% [29]. Because the
patients in this study were overventilated, their respiratory-
related energy expenditure was probably artefactually
high. Hyperventilation-corrected values fell in the 10-15%
range. To the best of our knowledge, the study with the
most similar design to the present study compared energy
expenditure during spontaneous breathing and mechanical
ventilation in 9 tracheotomized patients with post-polio
chronic respiratory failure [30]. In these patients, REE
decreased from 1378 (958—1607) kcal/24 h during spon-
taneous breathing to 1086 (598—1579) kcal/24 h during
pressure support ventilation (22%), and V'O2 decreased
from 207 (141—235) ml/min) to 159 (92—230)(23%). The
REE reduction observed during NIV in our ALS patients
(median 7%) and it V'O2 counterpart are therefore in the
upper range of available normal values for respiratory V'O2
and in the lower range of reported values in patients. In
addition to the possible underestimation discussed above, it
must be emphasized that our patients mostly depended
on their inspiratory neck muscles to breathe, as their
diaphragm did not participate in ventilation.
REE in ALS
In our patients, REESB was on average 10% lower than the
value predicted by the Harris and Benedict equation.
Of note, in the literature the prediction error for the
Harris-Benedict equation has been reported to be as highas 18.6 + 14.9%, with limits of agreement showing that
this equation could overestimate caloric expenditure by
591 kcal/d and underestimate requirements by 677 kcal/d
[31,32]. The energy requirements in ALS is a complex
issue see review in [33] and the details are beyond the
scope of this discussion. Some studies have shown that
one-half to two-thirds of ALS patients can be described as
"hypermetabolic" [5-7] and remain so throughout the
course of the disease [5]. In comparison with these
studies, our patients had a slightly lower BMI, which,
although fat-free mass was not measured, tends to suggest
that they were somewhat malnourished. More import-
antly, the respiratory status of our patients was poorer
than that reported in other studies, as our study appears
to be the first to provide REE measurements during spon-
taneous breathing in ALS patients meeting the criteria for
mechanical ventilation (Ellis and Rosenfeld measured REE
in ALS patients requiring NIV, but it is unclear from their
article whether the measurements were obtained during
spontaneous breathing or under NIV)[32]. Our patients
had a mean FVC of 42.7 ± 5.9% when REESB was deter-
mined, compared with a mean FVC close to 80% in the
studies by Desport et al. [6,7]. In the longitudinal study by
Bouteloup et al. [5], the 28 patients with sequential REE
measurements had a mean VC of 67% at the time of the
last measurement. In the longitudinal study by Kasarkis et
al [34], performed before the NIV era, some patients were
and remained hypermetabolic during the course of the
disease, but the lowest observed FVC in this population
was greater than 50%. It is therefore possible that the
development of respiratory insufficiency in ALS has
a masking effect on hypermetabolism, as suggested by
Vaisman et al. [35]. This could occur via various mecha-
nisms, including increasing malnutrition [33,35] due to
the combination of ALS-related impairment of swallowing
and/or eating-related dyspnea [36], as described in other
types of severe chronic respiratory insufficiency [37,38].
Of note, energy expenditure in ventilated ALS patients has
been found to be low [8,39], with results comparable to
those observed in ventilator-dependent Duchenne patients
[40], but it has also been found to be increased. Sherman
et al. observed hypermetabolism in ventilated patients
[31], and Ellis and Rosenfeld observed moderately in-
creased REE values in patients requiring NIV [32]. In both
cases, mean BMI values were about 25 kg.m-2, vs. 22 in
our patients, which might explain the discordant results.
In any case, the present study showed that REE decreased
under NIV in patients who were not hypermetabolic but
who tended to be hypometabolic (possibly because of
some degree or malnutrition): the amount of energy
expenditure spared by NIV would probably have been
even greater in better nourished patients. Also worthy of
notice, the effect of NIV on REE was quite heterogeneous
in our patients (Figure 2). We did not evidence any
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was similar in the 10 patients studied upon NIV initiation
and in the 6 patients studied somewhat later, and the
correction of hypoventilation was excellent and homoge-
neous in the study population (Table 2). In addition, the
REE response to NIV did not correlate with any of the an-
thropometric, respiratory or neurological variables collected.
Conclusions
There is a general consensus that NIV prolongs survival
and improves quality of life in ALS patients, and parti-
cularly those without severe bulbar dysfunction. These
positive outcomes are implicitly attributed to the correction
of hypoventilation and nocturnal desaturations, and to the
relief of dyspnea. In the light of the present observations, it
might be hypothesized that NIV could also be beneficial, in
certain cases, by reducing energy expenditure and therefore
contributing to a better nutritional equilibrium —the prog-
nostic value of which has been established—. Data from
Lechtzin et al. [41] have suggested that starting NIV early
in the course of respiratory involvement can be associated
with improved survival (an average gain of one year in
a population with a mean FVC of 74.3 ± 10.1% pred —
absence of obvious respiratory insufficiency—, in compari-
son with a population with a mean FVC of 48.3 ± 11.3%
pred). These results must be taken with caution because
they have not been prospectively corroborated and could,
at least in part, be due to a time bias effect. However, our
observations point at a putative mechanism for a beneficial
effect of early NIV, namely a reduced respiratory-related
energy expenditure. Of note, the accelerated muscle wast-
ing due to hypermetabolism is bound to involve respiratory
muscles. A NIV-related reduction in energy expenditure
could therefore theoretically contribute to slow respiratory
decline, yet a recent retrospective study suggested, appar-
ently for the first time, that NIV could indeed decrease the
ALS-related decline of VC [42]. The correlation observed
between REE and FVC and PiMAX in our patients (Table 3)
tends to supports this hypothesis. Nevertheless, NIV may
prove difficult to implement in asymptomatic patients.
Proposing "early NIV" with the purpose of reducing energy
expenditure would require prior convincing documentation
of the corresponding clinical benefits. Further studies are
therefore needed to elucidate what determines the response
of REE to NIV and whether, in what particular population,
and to what extent, early NIV can be beneficial in
ALS through a reduction in respiratory-related energy
expenditure. The role of ventilatory mode and triggering
modalities is among the factors to be studied.
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